Targeting microglial inflammation in Parkinson’s disease: irisin activates PAFAH1B1-RAGE ubiquitination and TFEB-dependent autophagy to alleviate neurodegeneration
Open Access
- 10 January 2026
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Abstract
Investigate irisin’s therapeutic potential in Parkinson’s disease (PD). Clinical data from 120 PD patients and 120 controls were analyzed. MPTP-induced PD mice and LPS-stimulated BV2 microglia models were used. In vivo, mice were divided into control, PD, and PD + Irisin groups for behavioral and histological assessments. In vitro, LPS-stimulated BV2 cells were treated with irisin or PBS. RNA sequencing, immunohistochemistry, and Western blot evaluated autophagy, inflammation, and ubiquitination pathways. PD patients exhibited increased TNF-α and IL-1β but decreased irisin levels. In PD mouse models, irisin improved motor deficits, increased nigrostriatal neuron numbers, restored tyrosine hydroxylase expression, and reduced α-synuclein aggregation. It also suppressed microglial inflammation and promoted anti-inflammatory polarization. Mechanistically, irisin enhanced autophagic flux, regulated RAGE ubiquitination mediated by PAFAH1B1, and inhibited neuroinflammation via the TFEB-NLRP3 axis. Specifically, PAFAH1B1 regulated RAGE expression through K61 and K169 sites on K48-linked polyubiquitin chains. Additionally, irisin restored lysosomal function by promoting TFEB nuclear translocation, enhancing NLRP3 inflammasome degradation, and reducing inflammatory factor secretion, thus alleviating neuroinflammation. Irisin alleviates PD pathology by modulating autophagy and ubiquitination pathways, suggesting its potential as a novel immunomodulatory target for PD.Keywords
This publication has 53 references indexed in Scilit:
- Irisin Regulates Microglia M1/M2 Polarization and Promotes Autophagy Through the Sirt3 Pathway to Alleviate POCDJournal of Neuroimmune Pharmacology, 2025
- Irisin reprograms microglia through activation of STAT6 and prevents cognitive dysfunction after surgery in miceBrain, Behavior, and Immunity, 2024
- Metabolic reprogramming and polarization of microglia in Parkinson’s disease: Role of inflammasome and ironAgeing Research Reviews, 2023
- Long-term voluntary exercise inhibited AGE/RAGE and microglial activation and reduced the loss of dendritic spines in the hippocampi of APP/PS1 transgenic miceExperimental Neurology, 2023
- Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s diseaseInflammation Research, 2023
- Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategiesAgeing Research Reviews, 2023
- Irisin protects against sepsis-associated encephalopathy by suppressing ferroptosis via activation of the Nrf2/GPX4 signal axisFree Radical Biology and Medicine, 2022
- α-Synuclein in Parkinson's disease and advances in detectionClinica Chimica Acta, 2022
- Inflammatory lncRNA AK039862 regulates paraquat-inhibited proliferation and migration of microglial and neuronal cells through the Pafah1b1/Foxa1 pathway in co-culture environmentsEcotoxicology and Environmental Safety, 2021
- α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2019